Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × pembrolizumab × Clear all

NCT03012620 2024-02-28

AcSé

Phase 2 Completed

CNSEndocrineGynecologicHead & NeckLymphoidSarcoma

Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Carcinoma, Neuroendocrine, Lymphoma, Extranodal NK-T-Cell

NCT03901378 2021-01-25

Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma

Phase 2 Withdrawn

Carcinoma, Neuroendocrine